Key statistics
On Friday, Actinium Pharmaceuticals Inc (ATNM:ASQ) closed at 1.18, 15.69% above the 52 week low of 1.02 set on Feb 18, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.16 |
|---|---|
| High | 1.22 |
| Low | 1.14 |
| Bid | 1.05 |
| Offer | 1.24 |
| Previous close | 1.15 |
| Average volume | 125.90k |
|---|---|
| Shares outstanding | 31.20m |
| Free float | 30.46m |
| P/E (TTM) | -- |
| Market cap | 36.81m USD |
| EPS (TTM) | -1.11 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting
- Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025
